Allurion Technologies stock soars on clinical study announcement
Shares of Allurion Technologies (NYSE: ALUR) skyrocketed by 350% following the company's announcement of its plans to ...
Hosted on MSN6d
Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk
Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.
Allurion Technologies Shares Are Up Today: What's Going On?
Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...
Allurion Technologies Inc trading halted, volatility trading pause
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Allurion extends rally despite $7.4M stock and warrants offering
Allurion Technologies (ALUR) stock climbed 200% despite a ~7.4M stock and warrants offering announced by the company. Read ...
Allurion Technologies Inc trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...
Allurion Shares Surge 185% Following $7.4 Million Fundraising Announcement
Shares of Allurion Technologies ( ALUR, Financials) surged 185% to $10.54 in midday trading after the company announced plans ...
Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs
Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular ...
CNN9mon
Allurion Technologies, Inc.
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric ...